| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |